BNP Paribas Financial Markets’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,107
Closed -$174K 3483
2024
Q1
$174K Buy
4,107
+1,799
+78% +$76.2K ﹤0.01% 2624
2023
Q4
$96.4K Buy
2,308
+1,078
+88% +$45K ﹤0.01% 2693
2023
Q3
$46.4K Sell
1,230
-903
-42% -$34.1K ﹤0.01% 2799
2023
Q2
$80.9K Buy
+2,133
New +$80.9K ﹤0.01% 2708
2022
Q4
Sell
-90
Closed -$2.7K 4020
2022
Q3
$2.7K Sell
90
-64
-42% -$1.92K ﹤0.01% 3602
2022
Q2
$5.57K Buy
154
+51
+50% +$1.84K ﹤0.01% 3172
2022
Q1
$4.46K Buy
+103
New +$4.46K ﹤0.01% 3290
2019
Q2
Sell
-22
Closed -$2.38K 3936
2019
Q1
$2.38K Hold
22
﹤0.01% 3520
2018
Q4
$1.86K Hold
22
﹤0.01% 3134
2018
Q3
$2.16K Sell
22
-1,745
-99% -$172K ﹤0.01% 3576
2018
Q2
$204K Sell
1,767
-1,714
-49% -$198K ﹤0.01% 1816
2018
Q1
$344K Buy
3,481
+1,745
+101% +$172K ﹤0.01% 1919
2017
Q4
$182K Hold
1,736
﹤0.01% 2365
2017
Q3
$196K Sell
1,736
-4,117
-70% -$464K ﹤0.01% 2161
2017
Q2
$656K Sell
5,853
-3,418
-37% -$383K ﹤0.01% 1546
2017
Q1
$1.08M Sell
9,271
-1,615
-15% -$188K ﹤0.01% 1147
2016
Q4
$1.15M Buy
10,886
+771
+8% +$81.2K 0.01% 1059
2016
Q3
$1.12M Buy
10,115
+6,455
+176% +$713K ﹤0.01% 891
2016
Q2
$533K Sell
3,660
-277
-7% -$40.3K ﹤0.01% 1487
2016
Q1
$564K Sell
3,937
-7,159
-65% -$1.03M ﹤0.01% 1167
2015
Q4
$1.71M Buy
11,096
+5,148
+87% +$796K ﹤0.01% 969
2015
Q3
$850K Buy
5,948
+5,494
+1,210% +$785K ﹤0.01% 1100
2015
Q2
$65.2K Buy
454
+430
+1,792% +$61.8K ﹤0.01% 2325
2015
Q1
$3.39K Buy
24
+1
+4% +$141 ﹤0.01% 3338
2014
Q4
$3.41K Buy
+23
New +$3.41K ﹤0.01% 1837